Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Near-infrared sensors and intramuscular glucose checks to detect poor blood flow in a fractured leg

Official title: Can Near Infrared Spectroscopy (NIRS) or Intramuscular Glucose Monitoring (IMGM) Detect Impaired Perfusion in the Anterior Compartment of the Leg in Patients With Tibial Fractures? "Proof of Concept" Pilot Study

Run by University of Florida · NCT06512870 · Data updated 2026-11-12

This study tests whether skin NIRS sensors and a muscle glucose measurement can detect reduced perfusion in adults with a tibial fracture and suspected compartment problems.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment10 (estimated)
SponsorUniversity of Florida
Academic / other
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedNovember 1, 2026
Study endsNovember 1, 2026
Registry record updatedJune 11, 2025
Trial IDNCT06512870 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 with a unilateral tibial fracture or fracture-dislocation complicated by acute compartment syndrome or documented loss of distal pulses, and with an anterior compartment depth under 2.5 cm, are ideal candidates.

Probably not a fit

People with deeper anterior compartments (>2.5–3 cm), open skin wounds over the compartment, prior fasciotomy on the affected leg, bilateral injuries, inability to consent, or who are not treated at the study site are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study enrolling adults with a unilateral tibial fracture and clinical or vascular signs of acute compartment syndrome. Bedside ultrasound is used to confirm the anterior compartment is shallow enough (<2.5 cm) for NIRS sensor placement, after which sensors are applied to the injured and the opposite uninjured leg for continuous monitoring until surgery. Investigators will also measure intramuscular glucose in the injured compartment and compare it to a fingerstick glucose to look for relative compartment hypoglycemia. Data are collected at UF Health (Gainesville) on a small cohort of about 7–10 patients to compare injured versus uninjured limb readings.

Why it matters

Potential benefit: If successful, these noninvasive or minimally invasive techniques could allow earlier detection of impaired leg perfusion and help guide timely surgical decisions to prevent muscle and nerve damage.

How similar studies have gone: NIRS has been used previously to monitor limb perfusion with mixed success and is not standard of care, while intramuscular glucose monitoring for compartment hypoperfusion is relatively novel and less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 18 years of age to 75 years of age
2. Diagnosis of tibial fracture or fracture-dislocation complicated by diagnosis of acute compartment syndrome AND/OR diagnosis of concomitant vascular injury with documented loss of pulses in the leg below the knee
3. Unilateral injury (i.e. only one leg is affected)

5\) Depth of anterior compartment of the leg \< 2.5 cm (as measured by ultrasound) 6) Willing to consent to the study

Exclusion Criteria:

1. Younger than 18 years of age or over 75 years of age
2. Skin damage, open wound or infection at the skin overlying the anterior muscular compartment, preventing NIRS sensor placement.
3. Depth to the muscle more than 3 cm as assessed with ultrasound.
4. History of fasciotomy performed on the affected leg.
5. Inability to obtain the informed consent from the patient of legal guardian or healthcare surrogate.
6. Language barrier- Inability to read or understand spoken English

Where it's running

  • UF Health
    Gainesville, Florida, United States
    Recruiting

Study contacts

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.